Pharmacodynamic biomarker of CDK4/6 inhibition: prospective evaluation of serum Cyclin D1, CDK4, and CDK6 in palbociclib-letrozole-treated metastatic breast cancer

帕博西利布 来曲唑 细胞周期蛋白依赖激酶6 医学 转移性乳腺癌 乳腺癌 细胞周期蛋白依赖激酶 肿瘤科 生物标志物 内科学 细胞周期蛋白D1 细胞周期蛋白依赖激酶4 癌症 药效学 癌症研究 细胞周期 临床意义 前瞻性队列研究 循环肿瘤细胞 富维斯特朗 激酶 临床试验 细胞周期蛋白D 细胞周期蛋白 CDK抑制剂 化疗
作者
Adnan Isamail,Eman Saadi Saleh,Ahmed Zuhair Alsammarraie
出处
期刊:Tropical Journal of Pharmaceutical Research [Pharmacotherapy Group, University of Benin, Benin City]
卷期号:25 (3): 339-346
标识
DOI:10.4314/tjpr.v25i3.6
摘要

Purpose: To evaluate the usefulness of serum cyclin D1, CDK4, and CDK6 as biomarkers of treatment response and progression-free survival (PFS) in metastatic breast cancer (MBC). Methods: In a single-center prospective observational study, 74 women with hormone-receptor-positive (HR+)/ human epidermal growth receptor-2 (HER2)-negative metastatic breast cancer were recruited from the Oncology Hospital, Medical City in Baghdad, Iraq. The patients were treated with oral Palbociclib (125 mg) for 21 days, then continued with Letrozole (2.5 mg) for 7 days, and completed six treatment cycles. The candidates were divided into two groups based on therapeutic response: Group 1 responded to the palbociclib plus letrozole combination therapy, and Group 2 did not. Serum cyclin D1, CDK 4, and CDK 6 levels were measured using enzyme-linked immunosorbent assay (ELISA) after the 6th cycle. Treatment response was evaluated using RECIST 1.1 criteria. The study was designed and reported in alignment with STROBE guidelines. Results: Serum cyclin D1 levels were higher in responders than non-responders (p = 0.070). Importantly, higher cyclin D1 levels were significantly associated with longer progression-free survival (PFS; p = 0.027). In contrast, serum CDK4 and CDK6 levels did not differ between groups and showed no predictive or prognostic value for PFS. Conclusion: Serum cyclin D1 has demonstrated prognostic relevance in palbociclib-treated MBC, supporting its role as a pharmacodynamic biomarker of CDK 4/6 inhibitors. These findings highlight the limitations of circulating intracellular kinase proteins and support further investigation of dynamic, tumor-derived biomarkers for treatment monitoring.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
小小书童完成签到,获得积分10
刚刚
118完成签到,获得积分10
刚刚
彩色鞋子发布了新的文献求助10
1秒前
Ho7T完成签到,获得积分10
1秒前
安彤发布了新的文献求助10
2秒前
充电宝的应助被冷酷以山采纳,获得10
2秒前
julie发布了新的文献求助10
2秒前
一秋一年发布了新的文献求助10
2秒前
dyxdyx发布了新的文献求助10
3秒前
dyd发布了新的文献求助10
3秒前
董家旭发布了新的文献求助10
3秒前
3秒前
3秒前
4秒前
科研完成签到 ,获得积分10
4秒前
Elaiuk发布了新的文献求助10
5秒前
wt发布了新的文献求助10
5秒前
佚名完成签到,获得积分10
5秒前
5秒前
SciGPT的应助被碧蓝白玉采纳,获得10
5秒前
科研通AI6.3的应助被1900采纳,获得10
5秒前
阿白完成签到,获得积分10
5秒前
Clover04的应助被月123采纳,获得10
6秒前
6秒前
Clover04的应助被月123采纳,获得10
6秒前
潇洒的诗桃完成签到,获得积分0
6秒前
无花果的应助被烹全鱼宴采纳,获得10
6秒前
NexusExplorer的应助被叫你吃布丁采纳,获得10
7秒前
8秒前
8秒前
水之形完成签到,获得积分10
8秒前
牟洪梅完成签到,获得积分10
9秒前
邢智翔发布了新的文献求助10
9秒前
ssgg发布了新的文献求助10
10秒前
10秒前
ding的应助被blackhawkwu采纳,获得20
10秒前
天天完成签到,获得积分10
10秒前
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181155
求助须知:如何正确求助?哪些是违规求助? 9571140
关于积分的说明 21816740
捐赠科研通 7777528
什么是DOI,文献DOI怎么找? 3433436
关于科研通互助平台的介绍 2557664
邀请新用户注册赠送积分活动 2479482